FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease
In 2014, two years after her Nobel Prize-winning invention of CRISPR-Cas9 genome editing, Jennifer Doudna thought the technology was mature enough to tackle a cure for a devastating hereditary disorder, sickle cell disease, ...
Mar 31, 2021
0
5